2022 Pharmacy Benefit Conference
In its fifth year, the 2022 Pharmacy Benefit Conference brought together the best and brightest professionals in pharmacy benefits management to cover value-based strategies that help employers design and deliver comprehensive yet affordable pharmacy benefits.
Virtual
On Demand
On-demand videos are now available.
Register for just $99 or for free for Employers Health clients.
Clients contact your client solutions executive for your coupon code.
Speakers & Topics
Biosimilars’ Impact on Health Care Trends and Cost
- Review of approved biosimilars in the US and market share trends
- Initial, current, and future biosimilar management trends
- Physician and Pharma response to biosimilar agents
- Biosimilar interchangeability and Authorized Biologics
- Biosimilar products in the pipeline
- Patient and healthcare system impact
Addressing Gene Therapy Financial Challenges
- Identify challenges associated with financing and reimbursement of cell and gene therapies
- Describe emerging products to address risks associated with these treatment options
- Discuss implications and potential actionable next steps
Robert O’Brien
Vice President Specialty
Real Endpoints
A Rocking Research Update on Biosimilar Uptake and Benefit Design Strategies: New mAbs on the Block
- Describe the therapeutic areas, pipeline, and regulatory environment affecting the biosimilar landscape
- Report results of current research on barriers to biosimilar adoption and impact of benefit design and formulary policies on utilization
- Discuss prospective payer management strategies in anticipation of market entry of pharmacy benefit biosimilars
Obesity Coverage Trends and the Financial Impact
- Background information on the inclusion of obesity benefits
- Overview of obesity coverage survey results regarding current trends and coverage decisions
- Comparison of the financial impact for different obesity utilization management strategies
Courtney Keefe
Clinical Advisor
Employers Health
Active Clinical Management and the Impact on the Pharmacy Benefit Plan
- Review the current selection of targeted clinical programs
- Discuss the financial impact of targeted clinical strategies
- Explore unintended consequences associated with exclusionary strategies
Tu Doan
Clinical Advisor
Employers Health
Federal and State Regulatory Efforts: Solving the Post-Rutledge Puzzle
- General overview of federal and state regulatory efforts
- Rutledge v. PCMA, its origins and the implications for self-funded plans
- Summary and cost impact of state legislation impacting the pharmacy benefit
Employer Best Practices
Join benefits professionals from three self-insured employers for a panel discussion where they’ll share:
- How their organizations are navigating COVID-19
- Strategies they are utilizing to address rising specialty spend
- How they are managing the constantly changing priorities faced by today’s benefits professionals